Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. Bhat TA, Dheeraj A, Nambiar DK, Singh SP, et al. Prostate 2023 Jan 3. doi: 10.1002/pros.24482.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bhat TA, Dheeraj A, Nambiar DK, Singh SP, et al. Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. Prostate 2023 Jan 3. doi: 10.1002/pros.24482.
PMID: 36597263